Literature DB >> 10447727

CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.

F Borrego1, M J Robertson, J Ritz, J Peña, R Solana.   

Abstract

CD69 is a differentiation antigen expressed shortly after activation on T lymphocytes and other cells of haematopoietic origin, including natural killer (NK) cells. The function of CD69 on T lymphocytes acting as a costimulatory molecule in proliferation and lymphokine secretion is well established. NK cells express CD69 after activation by different stimuli such as phorbol 12-myristate 13-acetate (PMA), interleukin (IL)-2, IL-12, interferon-alpha (IFN-alpha) or anti-CD16 monoclonal antibodies (mAbs). However, although it has been shown that CD69 triggers NK-cell-mediated cytolytic activity, its effect on other NK-cell functions has not been studied. Furthermore, the possible interaction of CD69 triggering with other C-lectin type inhibitory receptors is not known. Thus, the objective of this work is to determine whether CD69-mediated NK cytotoxicity can be regulated by CD94 inhibitory receptor and the role of CD69 on other NK-cell functions different of cytotoxicity. The results show that CD69-mediated NK cytotoxicity can be abrogated by CD94 stimulation in NK cells expressing the CD94 inhibitory form of the receptor, indicating that CD94 regulates the cytotoxic events initiated by a wide variety of NK activatory receptors. We also show that anti-CD69 mAbs, not only triggered NK cytotoxicity, but also induce NK-cell proliferation, CD25 and intracellular adhesion molecule-1 (ICAM-1) expression, TNF-alpha production and Ca2+ mobilization in preactivated NK cells. These results suggest that CD69 plays a crucial role in NK-cell function contributing to sustain NK-cell activation, as it has been previously demonstrated in T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447727      PMCID: PMC2326810          DOI: 10.1046/j.1365-2567.1999.00738.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69.

Authors:  P Sánchez-Mateos; F Sánchez-Madrid
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

2.  Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.

Authors:  A G Santis; M R Campanero; J L Alonso; A Tugores; M A Alonso; E Yagüe; J P Pivel; F Sánchez-Madrid
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

3.  Costimulatory signals are required for optimal proliferation of human natural killer cells.

Authors:  M J Robertson; T J Manley; C Donahue; H Levine; J Ritz
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

4.  CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms.

Authors:  R Gavioli; A Risso; D Smilovich; I Baldissarro; M C Capra; A Bargellesi; M E Cosulich
Journal:  Cell Immunol       Date:  1992-06       Impact factor: 4.868

5.  Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain.

Authors:  J Hamann; H Fiebig; M Strauss
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

6.  Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens.

Authors:  S F Ziegler; F Ramsdell; K A Hjerrild; R J Armitage; K H Grabstein; K B Hennen; T Farrah; W C Fanslow; E M Shevach; M R Alderson
Journal:  Eur J Immunol       Date:  1993-07       Impact factor: 5.532

7.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

8.  Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.

Authors:  F Borrego; J Peña; R Solana
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

9.  Stimulation of Fc gamma RIIIA results in phospholipase C-gamma 1 tyrosine phosphorylation and p56lck activation.

Authors:  L Azzoni; M Kamoun; T W Salcedo; P Kanakaraj; B Perussia
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.

Authors:  A Moretta; A Poggi; D Pende; G Tripodi; A M Orengo; N Pella; R Augugliaro; C Bottino; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  51 in total

1.  IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

Authors:  Gordana Konjević; Viktor Jović; Vladimir Jurisić; Sinisa Radulović; Svetislav Jelić; Ivan Spuzić
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

2.  A Listeria-derived polypeptide promotes in vivo activation of NK cells for antitumor therapy.

Authors:  Amber L Ortiz; Laurel L Lenz
Journal:  Immunohorizons       Date:  2017-06-26

3.  Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity.

Authors:  Stergios Katsiougiannis; David Chia; Yong Kim; Ram P Singh; David T W Wong
Journal:  FASEB J       Date:  2016-11-28       Impact factor: 5.191

4.  Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.

Authors:  Xing-Xing Yu; Ting-Ting Han; Ling-Ling Xu; Ying-Jun Chang; Xiao-Jun Huang; Xiang-Yu Zhao
Journal:  J Cell Mol Med       Date:  2018-03-25       Impact factor: 5.310

5.  Identification and characterization of a spliced C-type lectin-like gene encoded by rat cytomegalovirus.

Authors:  S Voigt; G R Sandford; L Ding; W H Burns
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Effect of a single and repeated dose of caffeine on antigen-stimulated human natural killer cell CD69 expression after high-intensity intermittent exercise.

Authors:  Deborah K Fletcher; Nicolette C Bishop
Journal:  Eur J Appl Physiol       Date:  2010-12-09       Impact factor: 3.078

7.  CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.

Authors:  A W Lin; S A Gonzalez; S Cunningham-Rundles; G Dorante; S Marshall; A Tignor; C Ha; I M Jacobson; A H Talal
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

8.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  LPS-induced systemic inflammation is more severe in P2Y12 null mice.

Authors:  Elisabetta Liverani; Mario C Rico; Laxmikausthubha Yaratha; Alexander Y Tsygankov; Laurie E Kilpatrick; Satya P Kunapuli
Journal:  J Leukoc Biol       Date:  2013-10-18       Impact factor: 4.962

10.  CD94 defines phenotypically and functionally distinct mouse NK cell subsets.

Authors:  Jianhua Yu; Min Wei; Hsiaoyin Mao; Jianying Zhang; Tiffany Hughes; Takeki Mitsui; Il-kyoo Park; Christine Hwang; Shujun Liu; Guido Marcucci; Rossana Trotta; Don M Benson; Michael A Caligiuri
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.